Research Peptide Database
37 compound profiles covering mechanism, evidence quality, physician practice protocols, and sourcing. Research use only.
37
COMPOUNDS
8
CATEGORIES
25
PROTOCOL REFS
Recovery
BPC-157
Stable gastric pentadecapeptide. Most-researched recovery compound in physician practice.
Physician Practice
View Profile →
Recovery
TB-500
Thymosin Beta-4 fragment. Systemic recovery with anti-inflammatory and angiogenic properties.
Physician Practice
View Profile →
Recovery
GHK
Copper-binding tripeptide. Collagen synthesis, wound healing, and anti-inflammatory research.
Physician Practice
View Profile →
GH / Performance
Ipamorelin
Selective GHRP with minimal cortisol/prolactin response. Clean GH pulse stimulation.
Physician Practice
View Profile →
GH / Performance
CJC-1295
GHRH analog with DAC modification for extended half-life. GH axis research.
Physician Practice
View Profile →
GH / Performance
Serm
First-generation GHRH analog. The foundational GH secretagogue with the longest practice history.
Physician Practice
View Profile →
Metabolic
Tessa
FDA-approved GHRH analog for HIV-associated lipodystrophy. Only approved GHRH analog in the US.
FDA-Approved
View Profile →
Metabolic
Tirze
FDA-approved dual GIP/GLP-1 agonist. Phase III data shows up to 22.5% mean weight loss at 72 weeks.
FDA-Approved
View Profile →
Metabolic
Reta
Investigational triple GIP/GLP-1/GCG agonist. Phase II shows 24% mean weight loss at 48 weeks.
Phase III
View Profile →
Metabolic
AOD-9604
hGH fragment (177-191) — the lipolytic domain of growth hormone. GRAS-listed.
Physician Practice
View Profile →
Metabolic
Cagrilintide
Long-acting amylin analog. Phase III CagriSema combination program with sema.
Phase III
View Profile →
Metabolic
Tesofensine
Triple monoamine reuptake inhibitor. Phase II shows 6.7–11.3% weight reduction. Oral.
Phase II
View Profile →
Longevity
NAD+
Cellular coenzyme for mitochondrial energy production, sirtuin activation, and DNA repair.
Physician Practice
View Profile →
Longevity
MOTS-c
Mitochondrial-derived peptide. AMPK activation and metabolic regulation. 2026 Phase 2a active.
Phase 2a Active
View Profile →
Longevity
SS-31
Elamipretide — mitochondria-targeted tetrapeptide that binds cardiolipin. Clinical trial compound.
Clinical Trials
View Profile →
Longevity
Epitalon
Pineal tetrapeptide studied for telomere elongation and circadian regulation. Russian research.
Physician Practice
View Profile →
Cognitive
Semax
ACTH(4-10) analog. BDNF upregulation, neuroprotection. Russian-approved for stroke/cognitive.
Russian Approved
View Profile →
Cognitive
Selank
Tuftsin-based anxiolytic heptapeptide. GABA-A modulation without dependency. Russian-approved.
Russian Approved
View Profile →
Cognitive
ADMAX
Longer-acting Semax analog (Adamax). Once-daily dosing advantage. Very limited independent data.
Physician Practice
View Profile →
Cognitive
P21
BDNF-mimetic neuropeptide. TrkB receptor agonism. Post-stroke/dementia physician practice.
Physician Practice
View Profile →
Immune
Thymulin
Zinc-dependent thymic hormone for T-cell maturation. Acute and chronic immune protocols.
Physician Practice
View Profile →
Immune
Thymosin Alpha-1
Zadaxin — approved in 40+ countries for hepatitis B/C. Most evidence-backed immune peptide.
Int’l Approved
View Profile →
Immune
KPV
Alpha-MSH tripeptide. NF-κB inhibition and GI protective research. Used in practice blends.
Physician Practice
View Profile →
Specialty
PT-141
Bremelanotide — FDA-approved Vyleesi for HSDD. MC3R/MC4R agonism. Phase III RECONNECT data.
FDA-Approved
View Profile →
Performance
IGF-1 LR3
Long-acting IGF-1 analog (~20hr half-life). WADA-prohibited. Significant oncological considerations.
WADA Prohibited
View Profile →
Specialty
Melanotan I
MC1R-selective alpha-MSH analog. FDA/EU-approved Scenesse for EPP photoprotection.
FDA-Approved
View Profile →
Specialty
Melanotan II
Non-selective melanocortin agonist. MC1R tanning, MC4R sexual function, MC3R energy research.
Investigational
View Profile →
Longevity
Glutathione 1500mg
Master endogenous antioxidant. ROS scavenging, hepatoprotection, skin lightening, Parkinson’s research.
Clinical Research
View Profile →
Metabolic
5-Amino-1MQ
NNMT inhibitor. Supports NAD+ pathway, adipocyte metabolism, and fat cell research.
Investigational
View Profile →
Blend — Skin
GLOW Blend
GHK + BPC-157 skin research blend. Collagen synthesis, wound repair, dermal angiogenesis.
Multi-Compound
View Profile →
Blend — Recovery
KLOW Blend
BPC-157 + TB-500 connective tissue blend. Tendon, ligament, cartilage, and joint repair research.
Multi-Compound
View Profile →
Blend — Longevity
LCS-26 Blend
Multi-compound longevity blend targeting senescence, mitochondrial function, and aging pathways.
Multi-Compound
View Profile →
Blend — Recovery
Recovery Peptide Blend
BPC-157 + TB-500 + GHK comprehensive tissue repair stack. Full-spectrum recovery research.
Multi-Compound
View Profile →
Blend — Metabolic
Lipotropic Complex Blend
Hepatic fat metabolism and lipid mobilization blend. Liver support and body composition research.
Multi-Compound
View Profile →
Cognitive
Semax + Selank
Russia-approved cognitive + anxiolytic stack. BDNF enhancement (Semax) + GABA modulation (Selank).
Russia-Approved
View Profile →
GH / Performance
CJC-1295 + Ipamorelin
Most-researched GH stack. GHRH amplitude + GHRP frequency. No cortisol elevation with Ipamorelin.
Physician Practice
View Profile →
GH / Performance
Tessa + Ipamorelin 18mg
FDA GHRH analog + selective GHRP. Strongest evidence-base GH stack. Combined 18mg vial.
FDA Component
View Profile →
No compounds match your search.
Get Personalized Research Guides
Tell us what you’re researching and we’ll send the right guide — compound pairings, dosing context, and sourcing for your category.
No spam. Research use only.